Tag: Cancer treatment

news-22072024-204234

Limited Benefit of Nivolumab/Tivozanib in Advanced RCC Post-Immunotherapy

The combination of nivolumab and tivozanib did not show an improvement in progression-free survival (PFS) for patients with advanced metastatic renal cell carcinoma (RCC)...
news-20072024-154835

Princess Kate’s Approach to Royal Engagements During Chemotherapy

Princess Kate has been taking a step back from her royal duties as she undergoes chemotherapy for her cancer diagnosis. Despite her absence, the...
innovent-announces-data-from-pivotal-phase-2-trust-i-study-of-taletrectinibros1-inhibitor-are-published-in-the-jco-and-reported-at-2024-asco-annual-meeting-thailand-business-news

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published...

Innovent Biologics Reveals Breakthrough Data from Phase 2 TRUST-I Study of Taletrectinib at 2024 ASCO Annual MeetingSAN FRANCISCO, U.S. and SUZHOU, China - Innovent...